Evidence map›Paper›PMID 34198807›Full record

ArticleInternational journal of environmental research and public health2021

Adoption of Tobacco 21: A Cross-Case Analysis of Ten US States.

Shawna V Hudson, Marin Kurti, Jenna Howard, Bianca Sanabria, Kevin R J Schroth, Mary Hrywna, Cristine D Delnevo

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Can States Continue to Set the Agenda for Tobacco 21? Insights From US News Coverage Between 2012 and 2020.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. A synthesis of local cigar pack policies in the US.Preventive medicine reports · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shawna V HudsonDepartment of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.ORCID 0000-0002-7026-0743
Marin KurtiDepartment of Sociology, Anthropology, Criminology and Social Work, Eastern Connecticut State University, 83 Windham Street Willmantic, CT 06226, USA.
Jenna HowardDepartment of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.
Bianca SanabriaDepartment of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.
Kevin R J SchrothRutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ 08901, USA.
Mary HrywnaRutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ 08901, USA.ORCID 0000-0002-0717-9598
Cristine D DelnevoRutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA.ORCID 0000-0001-9597-4307
Rutgers, The State University of New Jersey · USEastern Connecticut State University · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
New Jersey Alliance for Clinical Translational Science: NJ ACTSUL1TR003017 · NCATS · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI PANETTIERI, REYNOLD ALEXANDER · 2019 to 2023
$28.9M
Evaluating implementation of Tobacco 21 laws in the U.S.R01CA231139 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Maria Hrywna, Amanda Kong · 2018 to 2026
$4.7M
NCATS NIH HHS UL1 TR003017NCATS NIH HHS UL1TR003017NCI NIH HHS P30 CA072720NCI NIH HHS P30CA072720NCI NIH HHS R01 CA231139NCI NIH HHS R01CA231139
6 · The paper itself

Abstract

Despite the recent push for Tobacco 21 legislation in the US and the national adoption of Tobacco 21, there is a paucity of data on the process of policy adoption. To explore the key factors that served as facilitators or challenges to the passage of state T21 laws that apply to the sale of all tobacco products to anyone under 21 years of age, we conducted a comparative, cross-case study in ten states that adopted Tobacco 21 between 2016 and 2019. Stakeholders from selected states were identified via snowball sampling, and interviews were conducted from November 2018 to March 2020. Three primary factors emerged as facilitators to the passage of state T21 laws: (1) increased attention on e-cigarettes as the product driving an overall increase in youth tobacco use and depiction of an "e-cigarette epidemic", (2) having at least one influential policy entrepreneur or champion, and (3) traction from other states or local municipalities passing T21 legislation. Challenges to T21's success included (1) influence of the tobacco industry, (2) the bill's low ranking among legislative priorities, and (3) controversy among advocates and policymakers over bill language. As e-cigarette rates spiked, T21 bills became legislative priorities, traction from other successful efforts mounted, and ultimately, the tobacco industry flipped from opposing to supporting T21 laws. Despite these favorable headwinds, advocates struggled increasingly to pass bills with ideal policy language.

Indexed as

Electronic Nicotine Delivery SystemsTobacco IndustryTobacco ProductsAdolescentHumansSmokingTobacco UseUnited Statese-cigaretteshealth behaviorpolicytobacco

Identifiers

PMID34198807
PMCPMC8201309
OpenAlexW3172240599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.